HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shaomeng Wang Selected Research

4- (3- methoxy- phenylsulfannyl)- 7- nitro- benzofurazan- 3- oxide

7/2007A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shaomeng Wang Research Topics

Disease

109Neoplasms (Cancer)
11/2022 - 07/2003
21Prostatic Neoplasms (Prostate Cancer)
01/2022 - 05/2004
21Leukemia
01/2021 - 01/2005
20Breast Neoplasms (Breast Cancer)
10/2020 - 11/2004
10Lymphoma (Lymphomas)
01/2020 - 01/2005
7Lung Neoplasms (Lung Cancer)
11/2022 - 06/2008
7Squamous Cell Carcinoma of Head and Neck
01/2016 - 11/2004
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021 - 02/2008
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 05/2012
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2016 - 07/2005
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2014 - 01/2005
4Pancreatic Neoplasms (Pancreatic Cancer)
04/2010 - 11/2005
4Parkinson Disease (Parkinson's Disease)
07/2006 - 02/2003
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2021
3Carcinogenesis
12/2021 - 11/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 07/2008
3Hypothermia
12/2019 - 08/2007
3Colonic Neoplasms (Colon Cancer)
10/2014 - 06/2008
3Carcinoma (Carcinomatosis)
11/2013 - 07/2003
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2008 - 01/2005
3Cocaine-Related Disorders (Cocaine Addiction)
07/2006 - 02/2003
3Schizophrenia (Dementia Praecox)
07/2006 - 10/2003
2COVID-19
01/2021 - 12/2020
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 03/2007
2Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 11/2013
2Graft vs Host Disease (Graft-Versus-Host Disease)
08/2017 - 04/2015
2Adenoid Cystic Carcinoma (Cylindroma)
02/2017 - 09/2015
2Osteosarcoma (Osteogenic Sarcoma)
01/2015 - 10/2014
2Ovarian Neoplasms (Ovarian Cancer)
07/2012 - 03/2012

Drug/Important Bio-Agent (IBA)

68Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2003
14Pharmaceutical PreparationsIBA
01/2017 - 07/2003
13GossypolIBA
08/2010 - 07/2003
11Inhibitor of Apoptosis ProteinsIBA
04/2016 - 02/2005
8Androgen Receptors (Androgen Receptor)IBA
01/2022 - 01/2018
8CaspasesIBA
08/2017 - 09/2004
6snake venom protein C activatorIBA
12/2021 - 08/2018
6Phosphotransferases (Kinase)IBA
12/2020 - 02/2006
6LigandsIBA
04/2020 - 10/2003
6Cisplatin (Platino)FDA LinkGeneric
02/2017 - 08/2004
6SM 164IBA
05/2012 - 12/2007
5Proteolysis Targeting ChimeraIBA
12/2021 - 08/2018
5enzalutamideIBA
01/2021 - 01/2016
5MethyltransferasesIBA
06/2020 - 07/2010
5N- benzhydryl- 5- (2- (methylamino)propanamido)- 3- (3- methylbutanoyl)- 6- oxodecahydropyrrolo(1,2- a)(1,5)diazocine- 8- carboxamideIBA
08/2017 - 04/2011
5Caspase 9IBA
05/2012 - 05/2004
4ErbB Receptors (EGF Receptor)IBA
07/2022 - 07/2006
4AndrogensIBA
01/2021 - 01/2007
4Estrogen ReceptorsIBA
04/2020 - 12/2016
4PeptidomimeticsIBA
12/2017 - 02/2013
4SAR405838IBA
12/2016 - 10/2014
4MI-219IBA
01/2016 - 03/2008
4Oncogene Proteins (Oncogene Protein)IBA
01/2015 - 06/2008
4Dopamine (Intropin)FDA LinkGeneric
08/2007 - 02/2003
3tyrosine receptor (receptor, tyrosine)IBA
11/2022 - 03/2012
3Carboplatin (JM8)FDA LinkGeneric
07/2022 - 11/2008
3Tyrosine Kinase InhibitorsIBA
07/2022 - 03/2012
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
06/2021 - 11/2019
3Lysine (L-Lysine)FDA Link
06/2020 - 07/2010
3Histones (Histone)IBA
06/2020 - 07/2010
3MI-773IBA
01/2019 - 01/2016
3Biological ProductsIBA
11/2016 - 11/2005
3Docetaxel (Taxotere)FDA Link
01/2016 - 02/2012
3gossypol acetic acidIBA
01/2016 - 08/2010
3X-Linked Inhibitor of Apoptosis ProteinIBA
04/2014 - 11/2006
3Biomarkers (Surrogate Marker)IBA
11/2013 - 02/2008
3Peptides (Polypeptides)IBA
05/2013 - 07/2010
3Caspase 3 (Caspase-3)IBA
01/2012 - 09/2008
3PolyphenolsIBA
11/2008 - 02/2005
3NF-kappa B (NF-kB)IBA
10/2008 - 11/2005
270-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
11/2022 - 11/2022
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2022 - 12/2006
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2022 - 01/2020
2Paclitaxel (Taxol)FDA LinkGeneric
07/2022 - 11/2008
2ChromatinIBA
01/2021 - 10/2017
2Cysteine (L-Cysteine)FDA Link
01/2021 - 05/2008
2Anaplastic Lymphoma KinaseIBA
11/2020 - 03/2016
2ARD-61IBA
10/2020 - 01/2020
2Fulvestrant (Faslodex)FDA Link
04/2020 - 12/2016
2Transcription Factors (Transcription Factor)IBA
12/2019 - 10/2017
2abirateroneIBA
01/2019 - 01/2016
2Amino AcidsFDA Link
01/2019 - 11/2016
2Adenosine Triphosphatases (ATPase)IBA
01/2019 - 08/2009
2indoleIBA
01/2018 - 11/2017
2compound 18IBA
01/2017 - 06/2015
2MM-401IBA
01/2017 - 01/2014
2CrizotinibIBA
03/2016 - 03/2012
2Androgen Antagonists (Antiandrogens)IBA
01/2016 - 01/2016
2nutlin 3IBA
01/2016 - 12/2009
2Apoptosis Regulatory ProteinsIBA
11/2015 - 05/2013
2BM-1197IBA
09/2015 - 01/2014
2molibresibIBA
06/2014 - 10/2013
2Messenger RNA (mRNA)IBA
11/2013 - 01/2004
2Pramipexole (Mirapex)FDA LinkGeneric
01/2012 - 06/2011
2MI 319IBA
04/2010 - 12/2009

Therapy/Procedure

48Therapeutics
07/2022 - 03/2003
11Castration
01/2022 - 08/2010
9Drug Therapy (Chemotherapy)
02/2017 - 11/2004
6Radiotherapy
01/2016 - 10/2003
5Oral Administration
10/2021 - 07/2013
2Immunotherapy
01/2021 - 01/2020